SUMMARY
Abstract
Acne vulgaris is a common dermatologic condition often leading to scarring and psychosocial burden. This prospective, open-label study evaluated 15 patients (ages 13–53, Fitzpatrick II–VI) with both active acne and acne scars treated using a fractional radiofrequency device (Fractora™, InMode). Each patient underwent three sessions at 3–4 week intervals, using 24-pin insulated or non-insulated tips depending on skin type. Clinical evaluations at 1, 3, and 6 months demonstrated significant reductions in acne lesions, scar severity, and overall skin appearance scores, with improvements continuing over time. No unexpected adverse events occurred.
Conclusion
Fractional RF (Fractora) was proven safe and effective for simultaneous treatment of active acne and acne scars across multiple skin types, including darker tones. Patients experienced progressive scar depth reduction, acne clearance, and overall skin rejuvenation with minimal downtime. These findings reinforce the role of fractional RF as a reliable and safe modality in acne and scar management, offering sustained clinical and cosmetic benefits.
TOPICS COVERED
- Use of Fractora fractional RF for acne and scar treatment
- Simultaneous improvement of active acne and acne scars
- Study population included Fitzpatrick II–VI skin types
- Comparison of insulated vs non-insulated pins for darker skin types
- Progressive skin improvements at 1, 3, and 6 months follow-up
- Safety profile: minimal downtime, no unexpected adverse events
